Literature DB >> 26700910

Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.

Yanyan Lou1, Chad V Pecot1, Hai T Tran1, Vikki J DeVito1, Xi Ming Tang2, John V Heymach1, Raja Luthra3, Ignacio I Wistuba2, Zhuang Zuo3, Anne S Tsao4.   

Abstract

Entities:  

Keywords:  Dual EGFR mutations; Lung adenocarcinoma; T790M germline mutation

Mesh：

Substances：

Year:  2015        PMID： 26700910      PMCID： PMC5119523          DOI： 10.1016/j.cllc.2015.11.003

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  20 in total

1.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

2.  Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.

Authors:  Juliann Chmielecki; Jasmine Foo; Geoffrey R Oxnard; Katherine Hutchinson; Kadoaki Ohashi; Romel Somwar; Lu Wang; Katherine R Amato; Maria Arcila; Martin L Sos; Nicholas D Socci; Agnes Viale; Elisa de Stanchina; Michelle S Ginsberg; Roman K Thomas; Mark G Kris; Akira Inoue; Marc Ladanyi; Vincent A Miller; Franziska Michor; William Pao
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

3.  EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Authors:  Susumu Kobayashi; Titus J Boggon; Tajhal Dayaram; Pasi A Jänne; Olivier Kocher; Matthew Meyerson; Bruce E Johnson; Michael J Eck; Daniel G Tenen; Balázs Halmos
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

4.  Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.

Authors:  Adi Gazdar; Linda Robinson; Dwight Oliver; Chao Xing; William D Travis; Junichi Soh; Shinichi Toyooka; Lori Watumull; Yang Xie; Kemp Kernstine; Joan H Schiller
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

5.  Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

Authors:  Michio Inukai; Shinichi Toyooka; Sachio Ito; Hiroaki Asano; Shuji Ichihara; Junichi Soh; Hiroshi Suehisa; Mamoru Ouchida; Keisuke Aoe; Motoi Aoe; Katsuyuki Kiura; Nobuyoshi Shimizu; Hiroshi Date
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

6.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Authors:  Laura P Stabile; Jennifer S Lyker; Christopher T Gubish; Weiping Zhang; Jennifer R Grandis; Jill M Siegfried
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

7.  High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.

Authors:  Shiu-Feng Huang; Hui-Ping Liu; Ling-Hui Li; Yuan-Chieh Ku; Yu-Ning Fu; Hsien-Yu Tsai; Ya-Ting Chen; Yung-Feng Lin; Wen-Cheng Chang; Han-Pin Kuo; Yi-Cheng Wu; Yi-Rong Chen; Shih-Feng Tsai
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

Review 8.  Defining clinically relevant molecular subsets of lung cancer.

Authors:  William Pao
Journal:  Cancer Chemother Pharmacol       Date:  2006-11       Impact factor: 3.333

9.  Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

Authors:  Nicolas Girard; Emil Lou; Christopher G Azzoli; Rekha Reddy; Mark Robson; Megan Harlan; Irene Orlow; Yasushi Yatabe; Khedoudja Nafa; Marc Ladanyi; Agnes Viale; Mark G Kris; Gregory Riely; Vincent Miller; Robert J Klein; Keitaro Matsuo; William Pao
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

10.  Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.

Authors:  Lucia Regales; Marissa N Balak; Yixuan Gong; Katerina Politi; Ayana Sawai; Carl Le; Jason A Koutcher; David B Solit; Neal Rosen; Maureen F Zakowski; William Pao
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240
View more
  13 in total

1.  Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.

Authors:  Shiwang Wen; Lei Dai; Lei Wang; Wenjian Wang; Duoguang Wu; Kefeng Wang; Zhanghai He; Aodi Wang; Hui Chen; Peng Zhang; Xiaowei Dong; Yu-An Dong; Kai Wang; Ming Yao; Minghui Wang
Journal:  Oncologist       Date:  2019-03-22

2.  Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.

Authors:  Lingfeng Chen; Minyan Chen; Jie Lin; Xiaoyan Chen; Xunbin Yu; Zhizhong Chen; Long Jin
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

3.  Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer.

Authors:  Chunxiang Li; Yalong Wang; Kai Su; Yu Liu; Liyu Wang; Bo Zheng; Na Yan; Dawei Yuan; Yanxiang Zhang; Liyan Xue; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-04

4.  Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.

Authors:  Ran Huo; Jinghua Li; Xiaofang Li; Junping Shi; Kunjie Wang; Jin Jiao; Yanhong Shang
Journal:  Oncologist       Date:  2020-06-11       Impact factor: 5.837

Review 5.  Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence.

Authors:  Teresa Troiani; Stefania Napolitano; Carminia Maria Della Corte; Giulia Martini; Erika Martinelli; Floriana Morgillo; Fortunato Ciardiello
Journal:  ESMO Open       Date:  2016-09-16

Review 6.  Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies.

Authors:  Anthony M Musolf; Claire L Simpson; Mariza de Andrade; Diptasri Mandal; Colette Gaba; Ping Yang; Yafang Li; Ming You; Elena Y Kupert; Marshall W Anderson; Ann G Schwartz; Susan M Pinney; Christopher I Amos; Joan E Bailey-Wilson
Journal:  Genes (Basel)       Date:  2017-01-17       Impact factor: 4.096

7.  Detection of epidermal growth factor receptor T790M mutation by allele-specific loop mediated isothermal amplification.

Authors:  Srividya Arjuna; Gunimala Chakraborty; Rajesh Venkataram; Pandyanda Nanjappa Dechamma; Anirban Chakraborty
Journal:  J Carcinog       Date:  2020-06-11

8.  Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.

Authors:  Qinfang Deng; Qiyu Fang; Hui Sun; Aditi P Singh; Mariam Alexander; Shenduo Li; Haiying Cheng; Songwen Zhou
Journal:  Cancer Med       Date:  2020-01-28       Impact factor: 4.452

Review 9.  Inherited lung cancer: a review.

Authors:  Viviane Teixeira Loiola de Alencar; Maria Nirvana Formiga; Vladmir Cláudio Cordeiro de Lima
Journal:  Ecancermedicalscience       Date:  2020-01-29

10.  Rational design of non-resistant targeted cancer therapies.

Authors:  Francisco Martínez-Jiménez; John P Overington; Bissan Al-Lazikani; Marc A Marti-Renom
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.